Not available
Quote | Check-Cap Ltd. (NASDAQ:CHEK)
Last: | $4.07 |
---|---|
Change Percent: | 3.41% |
Open: | $4.1146 |
Close: | $4.07 |
High: | $4.24 |
Low: | $4.07 |
Volume: | 19,419 |
Last Trade Date Time: | 10/02/2023 03:00:00 am |
News | Check-Cap Ltd. (NASDAQ:CHEK)
SYMETRYX OPPOSES CHEK CAP/KEYSTONE MERGER, WILL EVALUATE OPTIONS TO STOP TRANSACTION PR Newswire TORONTO , Sept. 21, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announces that it has reviewed the filings between CHECK-CAP Ltd. ("Check-Cap") and K...
2023-08-17 10:07:42 ET Gainers: CervoMed ( CRVO ) +86% . Tivic Health Systems ( TIVC ) +34% . Jupiter Wellness ( JUPW ) +11% . NEXGEL ( NXGL ) +9% . Kamada ( KMDA ) +8% . Losers: Check-Cap ( CHEK ) -23% . ...
Message Board Posts | Check-Cap Ltd. (NASDAQ:CHEK)
Subject | By | Source | When |
---|---|---|---|
So are they actually doing anything? How do | antman | investorshub | 04/11/2023 2:21:03 AM |
znewcar1: $CHK hh 107 hod.74.47 ML69.68 yet pop and pulling off 72 | znewcar1 | investorshangout | 03/20/2023 3:47:54 PM |
znewcar1: $CHEK hold3.42 and broke to hod3.69 Could BO channel and push to >teens #MOON | znewcar1 | investorshangout | 02/13/2023 5:23:27 PM |
znewcar1: $CHEK 36% v575K c5.78 f5,800M H5.90 ML2.52 morning pushs and EOD to double the vol. day tw | znewcar1 | investorshangout | 02/07/2023 12:36:07 AM |
znewcar1: $CHEK any thoughts here! 3 time attack @5.6 finially pushed over does 5.38 hold | znewcar1 | investorshangout | 02/06/2023 7:13:11 PM |
Check-Cap Ltd. Company Name:
CHEK Stock Symbol:
NASDAQ Market:
TORONTO, Sept. 21, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announces that it has reviewed the filings between CHECK-CA...
SYMETRYX OPPOSES CHEK CAP/KEYSTONE MERGER, WILL EVALUATE OPTIONS TO STOP TRANSACTION PR Newswire TORONTO , Sept. 21, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announces that it has reviewed the filings between CHECK-CAP Ltd. ("Check-Cap") and K...
Proposed business combination to create a Nasdaq-listed medical device company focused on advancing the commercial execution and market development of Keystone’s comprehensive portfolio of implants, arches and other tooth replacement solutions Keystone 2022 revenues exceeded $60 mi...